The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Blueprint Medicines; Eisai
Characterization of genomic landscape using comprehensive circulating cell-free tumor DNA next generation sequencing in advanced thyroid carcinoma.
 
Valentina Tarasova
No Relationships to Disclose
 
Jill Tsai
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Travel, Accommodations, Expenses - Guardant Health
 
Bryan McIver
Honoraria - Blueprint Medicines; Eisai; Exelixis; Loxo/Lilly; MJH Life Sciences
Consulting or Advisory Role - Eisai; Exelixis; Loxo/Lilly
Speakers' Bureau - Loxo/Lilly
 
Julie E. Hallanger-Johnson
Consulting or Advisory Role - HRA Pharma
 
Colleen Veloski
Employment - Johnson & Johnson (I)
 
Sarimar Agosto Salgado
No Relationships to Disclose
 
Jude Masannat
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Travel, Accommodations, Expenses - Guardant Health
 
Leylah Drusbosky
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Travel, Accommodations, Expenses - Guardant Health
 
Christine H. Chung
Consulting or Advisory Role - Exelixis; Merck; Sanofi/Regeneron
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Ignyta (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst)